Anti-Snoring Market Trends

Statistics for the 2023 & 2024 Anti-Snoring market trends, created by Mordor Intelligence™ Industry Reports. Anti-Snoring trend report includes a market forecast to 2029 and historical overview. Get a sample of this industry trends analysis as a free report PDF download.

Market Trends of Anti-Snoring Industry

The Continuous Positive Airway Pressure (CPAP) Devices Sub-segment is Expected to Hold a Significant Market Share Over The Forecast Period

CPAP stands for continuous positive airway pressure. A CPAP device is a machine that uses mild air pressure to keep breathing airways open while a person is asleep. CPAP is an effective treatment for moderate to severe obstructive sleep apnea. CPAP machine includes a mask that fits over the nose or nose and mouth, straps to position the mask, a tube that connects the mask to the machine's motor, and a motor that blows air into the tube.

The development of new products, approvals, and launches indicates the high demand for CPAP devices in developing countries, which is propelling the growth of the market segment. For instance, in June 2021, the Indian Institute of Technology, Ropar, developed a device named 'Jivan Vayu,' which can be used as a substitute for a CPAP machine. This is the nation's one of the first such devices that functions even without electricity and is adapted to oxygen generation units like O2 cylinders and oxygen pipelines in hospitals. These provisions are not available in otherwise existing CPAP machines. Such development of advanced products in developing countries is also augmenting the market segment's growth.

Furthermore, in April 2021, Philips Respironics launched a new and improved auto CPAP machine named DreamStation 2 CPAP in the United States. The development of the Advanced DreamStation 2 has refined the overall auto CPAP machine into a lighter, more compact unit. The device is completely redesigned with a focus on enhancing CPAP therapy for patients. Additionally, in August 2021, ResMed launched AirSense 11, the company's next-generation CPAP device, designed to treat and manage obstructive sleep apnea. AirSense 11 includes new features like a personal therapy assistant and care check-in designed to provide tailored guidance to CPAP users, helping ease them into therapy and comfortable nightly use.

Therefore, owing to the launches of technologically advanced CPAP Devices and the high burden of sleep disorders, the segment is expected to witness significant growth during the forecast period.

Anti-Snoring Market: Estimated Funding by Government for Sleep Research (in USD million), United States, 2021 - 2023

North America is Expected to Dominate the Market During the Forecast Period

North America is expected to dominate the market owing to factors such as the high incidence of sleep diseases, high research and development (R&D) spending, product launches, and approvals, along with the high concentration of market players in the region.

For instance, according to the Centers for Disease Control and Prevention, Sleep and Sleep Disorders statistics, updated in November 2022, the age-adjusted prevalence of short sleep duration in the United States was 34% in females and 35.8% in males. Additionally, the article published in the American Journal of Respiratory and Critical Care Medicine in December 2021 reported that the global prevalence of obstructive sleep apnea was 22.6% last year. Such a high burden of obstructive sleep apnea creates a need for CPAP devices and thus drives the growth of the market segment.

Furthermore, according to the National Institute of Health, Estimates of Funding for Various Research, Condition, and Disease Categories (RCDC), May 2022 update, the spending on R&D in the United States for sleep research was USD 493 million last year and USD 515 million this year. The grant provided by the government for sleep research is expected to create opportunities for market players to develop innovative devices for the management and treatment of such diseases, which is further expected to propel market growth in the upcoming years.

Additionally, the rising product launches in the region are also contributing significantly to market growth. For instance, in February 2021, the United States Food and Drug Administration (US FDA) approved the commercialization of a prescription-only anti-snoring device, 'eXciteOSA,' developed by Rotech Healthcare. It delivers electrical muscle stimulation via a mouthpiece that is placed around the tongue. Therefore, owing to the above-mentioned factors, such as the high burden of sleep disorders, rising R&D spending, and product approvals and launches by market players, the growth of the studied market is anticipated in the North American Region.

Anti-Snoring Market - Growth Rate by Region

Anti-Snoring Devices Market Size & Share Analysis - Growth Trends & Forecasts (2024 - 2029)